New studies link the effects of caffeine to memory processes. A new hope, even if not immediate, for Alzheimer's patients
Alzheimer's, the 10 premonitory symptoms
Caffeine could be a turning point in research to combat Alzheimer's.
Suffering from Alzheimer's disease means seeing the memories of a lifetime pass before one's eyes, which are, after all, what defines us. A drama that leads to the constant search for a cure, as well as an element capable of counteracting progressive degeneration.
Specifically, the disease results in a slow but inexorable decline of nerve cells, as well as contacts between them. A neurodegenerative pathology, which today is considered irreversible, since no experimented treatment has yet managed to give comforting and meaningful effects.
Several research centers involved in the study of Alzheimer's disease, in order to discover more and more, approaching a possible cure day after day. Scientists at the Jean-Pierre Aubert Research Center, active at the University of Lille, in France, have implemented a new approach.
If it is true that aging is the primary factor for Alzheimer's disease, it is undeniable that environmental and genetic factors also play a role in this regard. Simplistic as it may seem, coffee consumption appears to have a significant impact on this risk.
Researchers' attention has focused on caffeine, which is the main constituent of coffee which, numbers in hand, is the most consumed beverage in the world after water. It can therefore be said that caffeine is the most consumed psychoactive substance in the world at all.
It has already been shown how it can stimulate excitement, faster information processing and, in general, cognitive processes in humans and animals. However, recent research developments also demonstrate an interesting connection with memory processes, with particular reference to long-term memory.
A regular consumption of coffee could therefore help reduce cognitive decline during human aging. A discovery that, observed from a purely practical point of view, leads to underline how the protective effects of caffeine are optimal in doses of 3-4 cups a day. Studies are continuing and, although it is still early to move on to experimentation on humans, it is comforting to know how the molecules derived from caffeine are also the subject of clinical studies on Parkinson's disease. No revolutionary announcement, therefore, but certainly a new hope.